Pharmagen 

$0
5
+$0+0% Wednesday 20:00

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
2,399
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
0
0.33
0.67
1
Expected EPS
0
Actual EPS
0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PHRX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with Pharmagen in various therapeutic areas, including vaccines, oncology, and immunology.
Merck
MRK
Mkt Cap214.76B
Merck operates in similar sectors as Pharmagen, focusing on pharmaceuticals and health solutions, particularly in areas like cancer treatment and vaccines.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a diversified healthcare giant that competes with Pharmagen across several segments, including pharmaceuticals, medical devices, and consumer health products.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie competes in the biopharmaceutical field, focusing on treatments for conditions such as rheumatoid arthritis and Crohn's disease, areas where Pharmagen may also be active.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is known for its antiviral drugs for HIV, hepatitis B, hepatitis C, and influenza, competing with Pharmagen in the development and marketing of treatments for infectious diseases.
AMGEN
AMGN
Mkt Cap160.66B
Amgen focuses on human therapeutics and competes with Pharmagen in areas such as oncology and cardiovascular disease.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases, competing with Pharmagen in multiple therapeutic areas.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that competes with Pharmagen by providing solutions in innovative medicines, generics, and biosimilars across a wide range of diseases.
Roche
RHHBY
Mkt Cap258.9B
Roche is a leader in research-focused healthcare with strengths in pharmaceuticals and diagnostics, competing with Pharmagen in areas such as oncology and infectious diseases.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global biopharmaceutical company focused on human health, competing with Pharmagen in areas like diabetes, vaccines, and rare diseases.

About

Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes. The company also manufactures and distributes health supplements, including Clotamin, a specialized over-the-counter multivitamin dietary supplement for patients on Warfarin. In addition, it sells traditional pharmaceuticals to its distribution customers, such as antibiotics, vaccines, and other oral and injectable pharmaceuticals; and specializes in the formulation of drugs. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013. Pharmagen, Inc. is based in Silver Spring, Maryland.
Show more...
CEO
Mr. Mackie A. Barch
Employees
24
Country
US
ISIN
US71715W1062

Listings

0 Comments

Share your thoughts

FAQ

What is Pharmagen stock price today?
The current price of PHRX is $0 USD — it has increased by +0% in the past 24 hours. Watch Pharmagen stock price performance more closely on the chart.
What is Pharmagen stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pharmagen stocks are traded under the ticker PHRX.
Is Pharmagen stock price growing?
PHRX stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Pharmagen has showed a +0% increase.
What were Pharmagen earnings last quarter?
PHRX earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Pharmagen have?
As of April 06, 2026, the company has 24 employees.
In which sector is Pharmagen located?
Pharmagen operates in the Health Care sector.
When did Pharmagen complete a stock split?
Pharmagen has not had any recent stock splits.
Where is Pharmagen headquartered?
Pharmagen is headquartered in Silver Spring, US.